Glaucoma
Conditions
Interventions
intravenous injection of [11C](R)-PK11195 (3MBq/kg body weight, 180MBq for 60 kg body weight)
Sponsors
Department of Ophthalmology and Visual Sciences, Graduate School of Medicine, Osaka City University
Department of Physiology, Graduate School of Medicine, Osaka City University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: patients with primary open angle glaucoma and healthy adults
Exclusion criteria
Exclusion criteria: High myopic eye ( more than -8.00 diopters), eyes with other diseases, eyes with highly advanced loss of visual fields, eyes with visual field loss due to other diseases, claustrophobic
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The presence or absence, if present the extent of intensiy , of accumulation at lateral geniculate body on PET | — |
Secondary
| Measure | Time frame |
|---|---|
| Perimetric changes, optic nerve cupping, changes of the optic nerve on MRI | — |
Countries
Japan
Outcome results
None listed